BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 27693460)

  • 1. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.
    Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM
    Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
    Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
    Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
    Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
    Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis.
    Liu G; Sun J; Yang ZF; Zhou C; Zhou PY; Guan RY; Sun BY; Wang ZT; Zhou J; Fan J; Qiu SJ; Yi Y
    Cell Death Dis; 2021 Mar; 12(3):260. PubMed ID: 33707417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
    Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.
    Fransvea E; Mazzocca A; Antonaci S; Giannelli G
    Hepatology; 2009 Mar; 49(3):839-50. PubMed ID: 19115199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion.
    Ren Y; Jia HH; Xu YQ; Zhou X; Zhao XH; Wang YF; Song X; Zhu ZY; Sun T; Dou Y; Tian WP; Zhao XL; Kang CS; Mei M
    Mol Cancer; 2018 Jan; 17(1):5. PubMed ID: 29325547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
    Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
    [No Abstract]   [Full Text] [Related]  

  • 12. The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth.
    Liu G; Yang ZF; Sun J; Sun BY; Zhou PY; Zhou C; Guan RY; Wang ZT; Yi Y; Qiu SJ
    Cell Oncol (Dordr); 2022 Dec; 45(6):1435-1449. PubMed ID: 36435866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.
    Bao S; Jin S; Wang C; Tu P; Hu K; Lu J
    J Cell Mol Med; 2020 Dec; 24(23):14110-14120. PubMed ID: 33118329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
    Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
    BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
    Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation.
    Mazzocca A; Fransvea E; Lavezzari G; Antonaci S; Giannelli G
    Hepatology; 2009 Oct; 50(4):1140-51. PubMed ID: 19711426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
    Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
    J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
    Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
    J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.